Skip to main content
Full access
Letter to the Editor
Published Online: 1 October 2002

Sibutramine and Panic Attacks

To the editor: Sibutramine, a nonamphetamine appetite suppressant, is a selective norepinephrine, serotonin, and—to a lesser extent—dopamine reuptake inhibitor (1). There have been previous reports of psychosis (2), depression, mood changes, palpitations, and chest tightness associated with sibutramine, and hypomania has been linked to the combination of sibutramine and citalopram (3). However, to our knowledge, there have been no reported exacerbations of panic attacks. We report on a patient who had a history of panic attacks and experienced a recurrence of panic symptoms shortly after starting sibutramine.
Ms. A, a 62-year-old woman, had been diagnosed as having panic attacks during her mid-20s and had been initially treated with anxiolytics. She had been panic-free without treatment since her mid-30s, except for two attacks, both of which had occurred after minor surgical procedures.
Ms. A started taking sibutramine, 10 mg/day, for weight loss. After 1½ weeks of taking sibutramine, she had two panic attacks in rapid succession. She discontinued the medication for several days and had no further attacks. She then restarted sibutramine and had another panic attack within approximately 3 days. She again discontinued sibutramine and has been asymptomatic for 5 months. Ms. A declined a third exposure to sibutramine. She was not unduly apprehensive about taking medication, and there were no obvious psychological stressors present at the time.
While it is not possible to definitively prove a causal relationship between sibutramine and panic attacks, the temporal relationship of the onset and disappearance of the panic attacks to the initiation and discontinuation of sibutramine is suggestive. With the Naranjo Adverse Drug Reactions Probability Scale (4), a high-probability relationship between sibutramine and the panic attacks was demonstrated in our patient. Although the mechanism for this reaction is unknown, physicians prescribing sibutramine should be aware of this potentially important side effect.

References

1.
McNeely W, Goa KL: Sibutramine: a review of its contribution to the management of obesity. Drugs 1998; 56:1093-1124
2.
Taflinski T, Chojnacka J: Sibutramine-associated psychotic episode (letter). Am J Psychiatry 2000; 157:2057-2058
3.
Benazzi F: Organic hypomania secondary to sibutramine-citalopram interaction (letter). J Clin Psychiatry 2002; 63:165
4.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1793-a - 1794

History

Published online: 1 October 2002
Published in print: October 2002

Authors

Affiliations

KAREN BINKLEY, M.D., F.R.C.P.C.
SANDRA R. KNOWLES, B.SC.PHM.
Toronto, Ont., Canada

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share